1
|
Shehab WS, Elsayed DA, Abdel Hamid AM, Assy MG, Mouneir SM, Hamed EO, Mousa SM, El-Bassyouni GT. CuO nanoparticles for green synthesis of significant anti-Helicobacter pylori compounds with in silico studies. Sci Rep 2024; 14:1608. [PMID: 38238369 PMCID: PMC10796945 DOI: 10.1038/s41598-024-51708-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2023] [Accepted: 01/08/2024] [Indexed: 01/22/2024] Open
Abstract
Helicobacter pylori (H. pylori) is a universal health intimidation as mentioned by the World Health Organization. The primary causal agent linked to a number of illnesses, including inflammation and the development of stomach ulcers, is Helicobacter pylori. Since, H. pylori develops antibiotic resistance quickly, current H. pylori treatment approaches are becoming less effective. Our research aims to highlight novel formulation antibiotics using CuO-NPs as catalysts and studied their activity as anti-helicobacter pylori supported by computational studies (POM analysis and molecular docking) software. They were designed for anti-Helicobacter Pylori action. All compounds revealed a bactericidal effect better than the reference McFarland standards.
Collapse
Grants
- STDF Open access funding provided by Te Science, Technology & Innovation Funding Authority (STDF) in cooperation with Te Egyptian Knowledge Bank (EKB).
- STDF Open access funding provided by Te Science, Technology & Innovation Funding Authority (STDF) in cooperation with Te Egyptian Knowledge Bank (EKB).
- STDF Open access funding provided by Te Science, Technology & Innovation Funding Authority (STDF) in cooperation with Te Egyptian Knowledge Bank (EKB).
- STDF Open access funding provided by Te Science, Technology & Innovation Funding Authority (STDF) in cooperation with Te Egyptian Knowledge Bank (EKB).
- STDF Open access funding provided by Te Science, Technology & Innovation Funding Authority (STDF) in cooperation with Te Egyptian Knowledge Bank (EKB).
- STDF Open access funding provided by Te Science, Technology & Innovation Funding Authority (STDF) in cooperation with Te Egyptian Knowledge Bank (EKB).
- STDF Open access funding provided by Te Science, Technology & Innovation Funding Authority (STDF) in cooperation with Te Egyptian Knowledge Bank (EKB).
- STDF Open access funding provided by Te Science, Technology & Innovation Funding Authority (STDF) in cooperation with Te Egyptian Knowledge Bank (EKB).
- STDF Technology & Innovation Funding Authority (STDF) in cooperation with Te Egyptian Knowledge Bank (EKB)., STDF
- STDF Technology & Innovation Funding Authority (STDF) in cooperation with Te Egyptian Knowledge Bank (EKB)., STDF
- STDF Technology & Innovation Funding Authority (STDF) in cooperation with Te Egyptian Knowledge Bank (EKB)., STDF
- STDF Technology & Innovation Funding Authority (STDF) in cooperation with Te Egyptian Knowledge Bank (EKB)., STDF
- STDF Technology & Innovation Funding Authority (STDF) in cooperation with Te Egyptian Knowledge Bank (EKB)., STDF
- STDF Technology & Innovation Funding Authority (STDF) in cooperation with Te Egyptian Knowledge Bank (EKB)., STDF
- STDF Technology & Innovation Funding Authority (STDF) in cooperation with Te Egyptian Knowledge Bank (EKB)., STDF
- STDF Technology & Innovation Funding Authority (STDF) in cooperation with Te Egyptian Knowledge Bank (EKB)., STDF
- Zagazig University
Collapse
Affiliation(s)
- Wesam S Shehab
- Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt.
| | - Doaa A Elsayed
- Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt.
| | - Atef M Abdel Hamid
- Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt
| | - Mohamed G Assy
- Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt
| | - Samar M Mouneir
- Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Cairo, 12211, Egypt
| | - Eman O Hamed
- Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt
| | - Sahar M Mousa
- Inorganic Chemistry Department, National Research Centre, 33 El-Buhouth St., Dokki, Cairo, 12622, Egypt
| | - Gehan T El-Bassyouni
- Ceramics and Building Materials Department, National Research Centre, 33 El-Buhouth St., Dokki, Cairo, 12622, Egypt
| |
Collapse
|
2
|
Alminderej F, Ghannay S, Omer Elsamani M, Alhawday F, Albadri AEAE, Elbehairi SEI, Alfaifi MY, Kadri A, Aouadi K. In Vitro and In Silico Evaluation of Antiproliferative Activity of New Isoxazolidine Derivatives Targeting EGFR: Design, Synthesis, Cell Cycle Analysis, and Apoptotic Inducers. Pharmaceuticals (Basel) 2023; 16:1025. [PMID: 37513936 PMCID: PMC10384175 DOI: 10.3390/ph16071025] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2023] [Revised: 07/11/2023] [Accepted: 07/16/2023] [Indexed: 07/30/2023] Open
Abstract
A series of novel enantiopure isoxazolidine derivatives were synthesized and evaluated for their anticancer activities against three human cancer cell lines such as human breast carcinoma (MCF-7), human lung adenocarcinoma (A-549), and human ovarian carcinoma (SKOV3) by employing MTT assay. The synthesized compounds were characterized by NMR and elemental analysis. Results revealed that all the synthesized compounds displayed significant inhibition towards the tested cell lines. Among them, 2g and 2f, which differ only by the presence of an ester group at the C-3 position and small EDG (methyl) at the C-5 position of the phenyl ring (2g), were the most active derivatives in attenuating the growth of the three cells in a dose-dependent manner. The IC50 for 2g were 17.7 ± 1 µM (MCF-7), 12.1 ± 1.1 µM (A-549), and 13.9 ± 0.7 µM (SKOV3), and for 2f were 9.7 ± 1.3µM (MCF-7), 9.7 ± 0.7µM (A-549), and 6.5 ± 0.9µM (SKOV3), respectively, which were comparable to the standard drug, doxorubicin. The enzymatic inhibition of 2f and 2g against EGFR afforded good inhibitory activity with IC50 of 0.298 ± 0.007 μM and 0.484 ± 0.01 µM, respectively, close to the positive control, Afatinib. Compound 2f arrested the cell cycle in the S phase in MCF-7 and SKOV3 cells, and in the G2/M phase in the A549 cell; however, 2g induced G0/G1 phase cell cycle arrest, and inhibited the progression of the three cancer cells, together with significant apoptotic effects. The docking study of compounds 2f and 2g into EGFR ATP-active site revealed that it fits nicely with good binding affinity. The pharmacokinetic and drug-likeness scores revealed notable lead-like properties. At 100 ns, the dynamic simulation investigation revealed high conformational stability in the EGFR binding cavity.
Collapse
Affiliation(s)
- Fahad Alminderej
- Department of Chemistry, College of Science, Qassim University, Buraidah 51452, Saudi Arabia
| | - Siwar Ghannay
- Department of Chemistry, College of Science, Qassim University, Buraidah 51452, Saudi Arabia
| | - Mohamed Omer Elsamani
- Department of Chemistry, Faculty of Science and Arts of Baljurashi, Al-Baha University, P.O. Box 1988, Albaha 65527, Saudi Arabia
- Department of Food Science and Technology, Faculty of Sciences, Omdurman Islamic University, Omdurman P.O. Box 382, Sudan
| | - Fahad Alhawday
- Department of Chemistry, College of Science, Qassim University, Buraidah 51452, Saudi Arabia
| | - Abuzar E A E Albadri
- Department of Chemistry, College of Science, Qassim University, Buraidah 51452, Saudi Arabia
| | - Serag Eldin I Elbehairi
- Department of Biology, Faculty of Science, King Khalid University, Abha 9004, Saudi Arabia
- Cell Culture Laboratory, Egyptian Organization for Biological Products and Vaccines, VACSERA Holding Company, Giza 2311, Egypt
| | - Mohammad Y Alfaifi
- Department of Biology, Faculty of Science, King Khalid University, Abha 9004, Saudi Arabia
| | - Adel Kadri
- Department of Chemistry, Faculty of Science and Arts of Baljurashi, Al-Baha University, P.O. Box 1988, Albaha 65527, Saudi Arabia
- Department of Chemistry, Faculty of Science of Sfax, University of Sfax, B.P. 1171, Sfax 3000, Tunisia
| | - Kaïss Aouadi
- Department of Chemistry, College of Science, Qassim University, Buraidah 51452, Saudi Arabia
- Department of Chemistry, Faculty of Science of Sfax, University of Sfax, B.P. 1171, Sfax 3000, Tunisia
- Department of Chemistry, Laboratory of Heterocyclic Chemistry Natural Product and Reactivity/CHPNR, Faculty of Science of Monastir, University of Monastir, Avenue of the Environment, Monastir 5019, Tunisia
| |
Collapse
|